Implantable cardioverter defibrillator therapy is cost effective for primary prevention patients in Taiwan: An analysis from the Improve SCA trial

OBJECTIVE: Implantable cardiac defibrillators (ICDs) for primary prevention (PP) of sudden cardiac arrest (SCA) are well-established but underutilized globally. The Improve SCA study has identified a cohort of patients called 1.5 primary prevention (1.5PP) based on PP patients with the presence of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Holbrook, Reece, Higuera, Lucas, Wherry, Kael, Phay, Dave, Hsieh, Yu-Cheng, Lin, Kuo-Hung, Liu, Yen-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676667/
https://www.ncbi.nlm.nih.gov/pubmed/33211698
http://dx.doi.org/10.1371/journal.pone.0241697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676667/
https://www.ncbi.nlm.nih.gov/pubmed/33211698
http://dx.doi.org/10.1371/journal.pone.0241697

Ejemplares similares